1. Clinical activity of CC‐90011, an oral, potent, and reversible LSD1 inhibitor, in advanced malignancies. Issue 17 (23rd June 2022) Authors: Hollebecque, Antoine; Salvagni, Stefania; Plummer, Ruth; Niccoli, Patricia; Capdevila, Jaume; Curigliano, Giuseppe; Moreno, Victor; de Braud, Filippo; de Villambrosia, Sonia Gonzalez; Martin‐Romano, Patricia; Baudin, Eric; Arias, Marina; de Alvaro, Juan; Parra‐Palau, Josep L.; Sánchez‐Pérez, Tani... Journal: Cancer Issue: Volume 128:Issue 17(2022) Page Start: 3185 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗